Skip to main content
Figure 2 | Arthritis Research & Therapy

Figure 2

From: Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients

Figure 2

Signal strengths of anti-PM/Scl-75 antibodies (a), but not of anti-PM/Scl-100 antibodies (b), depend on the underlying disease. Sera from patients with diffuse systemic sclerosis (dSSc), limited systemic sclerosis (lSSc), overlap syndromes, and undifferentiated systemic sclerosis patients were analyzed by line immunoblot assay. PM, polymyositis; RA, rheumatoid arthritis; SLE, systemic lupus erythematosus; SS, Sjögren syndrome; U, units; UCTD, undifferentiated connective tissue disease.

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us